Выпуск
Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments
Pharmaceutical Executive · 22 сентября 2026 г. · 2 мин
Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand therapy asset from BoomRay Pharmaceuticals, and Rafaat Rahmani argues that the costliest competitive intelligence failure is missing the moment a strategic assumption goes wrong.